PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91020F00014COVID activ3 TASK ORDER supports niaid's — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Recompete timing centers on the Sep 29, 2029 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci
Awarding office
Leidos Biomedical Research, Inc
Recipient
Sep 29, 2029
PoP end
$0
Obligated
$50M
Potential
541715
NAICS
AN12
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Leidos Biomedical Research, Inc — $90

Contract facts

Federal
Contract number75N91020F00014
Also listed as75N91019D00024-75N91020F00014
AgencyNih Nci
Awarding officeNih Nci
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentLeidos Biomedical Research, Inc
CAGE3LYK6
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK MD
Pricing typeCost Plus Fixed Fee
Extent competedFull And Open Competition
PoP startJun 30, 2020
PoP end (current)Sep 29, 2029
Obligated$0
Current value$50M
Potential value$50M

COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA is a federal award for Nih Nci held by Leidos Biomedical Research, Inc. Estimated value $50M ($0 obligated). Current period of performance ends Sep 29, 2029. Place of performance: FREDERICK MD.

COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA

Recompete timing

Public
Expiring in 1116 days

Current PoP ends Sep 29, 2029 (1116 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 29, 2028.

Incumbent footprint

Public record

Leidos Biomedical Research, Inc$2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$2.1B · 100% of firm total
Open full company profile

Related awards

Same parent · incumbent
75N91021F00017
ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
$12.1M
Sep 15, 2026
75N91021F00016
DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS
$6.6M
Sep 15, 2026
75N91021F00018
INFRASTRUCTURE IMPROVEMENTS
$4.6M
Sep 24, 2026
HHSN26100039
RETROSPECTIVE TUMOR CHARACTERIZATION ANALYSIS (MOONSHOT)
$21.3M
Sep 30, 2026
75N91018F00080
HHSN261201500003I; HHSN26100080; 400.001.0080.0001; NCI OD-FREDERICK; APPROPRIATED; 125073…
$10.0M
Oct 2, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75N91020F00014?

75N91020F00014 (COVID activ3 TASK ORDER supports niaid's) is a Nih Nci award with a potential value of $50M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91020F00014?

Nih Nci awarded 75N91020F00014 to Leidos Biomedical Research, Inc (potential $50M).

Who is the incumbent on 75N91020F00014?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2029.

When does Leidos Biomedical Research, Inc’s 75N91020F00014 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2029. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91020F00014 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91020F00014